MedTrace Logo

Intralesional Vitamin D Injection for Treatment of Common Warts

NCT04278573 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2024-04-30

Study results available
· View outcomes & findings →

Summary

Researchers are trying to find out if injecting Vitamin D into a wart is an effective treatment.

Conditions

  • Warts

Interventions

DRUG

Vitamin D3

Intralesional injection of 0.3 ml 40,000 IU/ml vitamin D3 into one wart

DRUG

Placebo

0.3 ml injection of sterilized sesame oil with no active study ingredient

Sponsors & Collaborators

  • Stephen P. Merry

    lead OTHER

Principal Investigators

  • Stephen Merry, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-20
Primary Completion
2023-04-04
Completion
2023-04-04
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04278573 on ClinicalTrials.gov